Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Adrienne A. Phillips & Koen van Besien. (2015) A new “age” for high dose therapy and autologous stem cell transplant. Leukemia & Lymphoma 56:8, pages 2233-2234.
Read now
Read now
Articles from other publishers (16)
Maoqin Li, Haihao Lu, Jiaoyang Fan, Min Dai & Chang Su. (2023) A nomogram prognostic model for diffuse large B‐cell lymphoma based on SUVmax and GNRI in elderly patients. eJHaem 4:4, pages 1030-1041.
Crossref
Crossref
Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Peter Brown, Tarec Christoffer El-Galaly & Thomas Stauffer Larsen. (2023) Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models. Blood Cancer Journal 13:1.
Crossref
Crossref
Juliette Pénichoux, Hélène Lanic, Caroline Thill, Anne-Lise Ménard, Vincent Camus, Aspasia Stamatoullas, Emilie Lemasle, Stéphane Leprêtre, Pascal Lenain, Nathalie Contentin, Jerôme Kraut-Tauzia, Christophe Fruchart, Leila Kammoun, Gandhi Damaj, Agathe Farge, Caroline Delette, Romain Modzelewski, Sandrine Vaudaux, Louis-Ferdinand Pépin, Hervé Tilly & Fabrice Jardin. (2023) Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study. Annals of Hematology 102:7, pages 1811-1823.
Crossref
Crossref
Antoine Herault, Emilie Lévêque, Simon Draye-Carbonnier, Pierre Decazes, Alexandra Zduniak, Romain Modzelewski, Julie Libraire, Najate Achamrah, Anne-Lise Ménard, Pascal Lenain, Nathalie Contentin, Maximilien Grall, Stéphane Leprêtre, Emilie Lemasle, Hélène Lanic, Mustafa Alani, Aspasia Stamatoullas-Bastard, Hervé Tilly, Fabrice Jardin, Fabienne Tamion & Vincent Camus. (2023) High prevalence of pre-existing sarcopenia in critically ill patients with hematologic malignancies admitted to the intensive care unit for sepsis or septic shock. Clinical Nutrition ESPEN 55, pages 373-383.
Crossref
Crossref
Salvatrice Mancuso, Marta Mattana, Marco Santoro, Melania Carlisi, Silvio Buscemi & Sergio Siragusa. (2022) Host‐related factors and cancer: Malnutrition and non‐Hodgkin lymphoma. Hematological Oncology 40:3, pages 320-331.
Crossref
Crossref
Renguo Guan, Weimin Guo, Weifeng Hong, Ye Lin, Xiongfeng Zou, Ning Shi, Dongyang Yang, Yu Zhou, Zhixiang Jian, Haosheng Jin, Weidong Lin & Min Yu. (2020) Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival. Frontiers in Oncology 10.
Crossref
Crossref
Taiki Ando, Shin Fujisawa, Haruka Teshigawara, Ayako Matsumura, Takayuki Sakuma, Taisei Suzuki, Hiroshi Teranaka, Eriko Ogusa, Yoshimi Ishii, Kazuho Miyashita, Hiroyuki Takahashi, Yuki Nakajima, Takuya Miyazaki, Maki Hagihara, Kenji Matsumoto, Etsuko Yamazaki & Hideaki Nakajima. (2020) Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. International Journal of Hematology 112:1, pages 46-56.
Crossref
Crossref
Vicki A. Morrison, Laurie Hamilton, Augustina Ogbonnaya, Aditya Raju, Kristin Hennenfent & Aaron Galaznik. (2020) Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma – Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007–2015. Journal of Geriatric Oncology 11:1, pages 41-54.
Crossref
Crossref
Yuko Matsubara, Keiichiro Nakamura, Hirofumi Matsuoka, Chikako Ogawa & Hisashi Masuyama. (2019) Pre‑treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer. Molecular and Clinical Oncology.
Crossref
Crossref
Alejandro Recio-Boiles, Jose N. Galeas, Bernard Goldwasser, Karla Sanchez, Louise M. W. Man, Ryan D. Gentzler, Jane Gildersleeve, Patricia J. Hollen & Richard J. Gralla. (2018) Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT). Supportive Care in Cancer 26:7, pages 2353-2359.
Crossref
Crossref
Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima & Yoshiharu Maeda. (2018) Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients. Hematological Oncology 36:1, pages 76-83.
Crossref
Crossref
Takanori Kiyotoki, Keiichiro Nakamura, Junko Haraga, Chiaki Omichi, Naoyuki Ida, Masayuki Saijo, Takeshi Nishida, Tomoyuki Kusumoto & Hisashi Masuyama. (2018) Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy. International Journal of Gynecologic Cancer 28:1, pages 168-175.
Crossref
Crossref
Terry Boyle, Joseph M. Connors, Randy D. Gascoyne, Brian R. Berry, Laurie H. Sehn, Morteza Bashash & John J. Spinelli. (2017) Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases. British Journal of Haematology 178:3, pages 442-447.
Crossref
Crossref
Shouichi Tanaka, Osamu Imataki, Atsuo Kitaoka, Shuji Fujioka, Etsuyo Hanabusa, Yumiko Ohbayashi, Makiko Uemura, Nobuo Arima & Tetsuji Yamamoto. (2017) Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation. Journal of Cancer Research and Clinical Oncology 143:6, pages 1083-1092.
Crossref
Crossref
Jennifer Totonchy & Ethel Cesarman. (2016) Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?. Current Opinion in Virology 20, pages 71-77.
Crossref
Crossref
Hee Sang Hwang, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh. (2015) Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified. Annals of Hematology 94:10, pages 1655-1665.
Crossref
Crossref